Changes in membrane enzymes and glycosphingolipids in lymphocytes from HIV-1-infected and noninfected intravenous drug users

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 11, Issue 2, 1996, Pages 188-197

  Leoni, Lorenzo M ^a   Losa, Gabriele A ^a  

^a INSTITUTE OF PATHOLOGY   (Switzerland)

Author keywords

5' nucleotidase; CALLA; Gangliosides; Glycosphingolipids; Human immunodeficiency virus type 1; Immunophenotype; Intravenous drug users; Neutral endopeptidase; Peripheral blood mononuclear cells; Phospholipase C; Plasma membrane enzymes; Glutamyltransferase

Indexed keywords

5' NUCLEOTIDASE; CD4 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; GAMMA GLUTAMYLTRANSFERASE; GANGLIOSIDE; GLYCOSPHINGOLIPID; MEMBRANE ENZYME; MEMBRANE METALLOENDOPEPTIDASE; PHOSPHOLIPASE C;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CELL MEMBRANE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; HELPER CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOPHENOTYPING; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION;

CALLA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0030031317     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199602010-00011     Document Type: Article

References (55)

1. Levy JA. HIV pathogenesis and long-term survival. AIDS 1993;7:1401-10.
2. Pantaleo G, Graziosi C, Fauci A. The immunopathogenesis of human immunodeficiency virus infection. N Engl J Med 1993;328:327-35.
3. Losa GA. Enzymatic imbalance in peripheral blood mononuclear cells isolated from individuals with anti-HIV antibodies. Clin Blochem 1989;22:321-8.
4. Foon KA, Gated RP, Todd RE. Recent advances in the immunologic classification of leukemia. Semin Hematol 1986; 23:257-83.
5. Shipp MA, Look TA. Hematopoietic differentiation antigens that are membrane-associated enzymes: cutting is the key. Blood 1993;82:1052-70.
6. Murray JL, Reuben JM, Munn CG. Decreased 5′-nucleotidase activity in lymphocytes from asymptomatic sexually active homosexual men and patients with acquired immune deficiency syndrome. Blood 1984;64:1016-21.
7. Murray JL, Loftin KC, Munn CG. Elevated adenosine de-aminase and purine nucleoside phosphorylase activity in peripheral blood null lymphocytes from patients with acquired immune deficiency syndrome. Blood 1985;65:1318-24.
8. Ganju RK, Sunday M, Tsarwhas DG, Card A, Shipp MA. CD10/NEP in non-small cell lung carcinomas. Relationship to cellular proliferation. J Clin Invest 1994;94:1784-91.
9. Patel M, Yanagishita M, Roderiquez G, et al. Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines. AIDS Res Hum Retroviruses 1993;9:167-74.
10. Yohe HC, Berenson CS, Cuny CL, Ryan JL. Altered B-lymphocyte membrane architecture indicated by ganglioside accessibility in C3H/HeJ mice. Infect Immun 1990;58:2888-94.
11. Ladisch S, Becker H, Ulsh L. Immunosuppression by human gangliosides: I. Relationship of carbohydrate structure to the inhibition of T cell responses. Biochim Biophys Acta 1992;1125:180-8.
12. 1 ganglioside by peripheral blood monocytes from patients with AIDS - evidence of monocyte activation in vivo. J Leuk Biol 1992;52:282-6.
13. 3 as a target of anti-lymphocytic ganglioside antibodies in AIDS patients. Clin Immunol Immunopathol 1993;67:216-23.
14. Fantini J, Cook DG, Nathanson N, Spitalnik SL, Gonzalez Scarano F. Infection of colonic epithelial cell lines by type 1 human immunodeficiency virus is associated with cell surface expression of galactosylceramide, a potential alternative gp120 receptor. Proc Natl Acad Sci USA 1993;90: 2700-4.
15. Bhat S, Mettus RV, Reddy PE, et al. The galactosyl ceramide/sulfatide receptor binding region of HIV-1 gp120 maps to amino acids 206-275. AIDS Res Hum Retroviruses 1993;9:175-81.
16. Smith TK, Meister A. Active deglycosylated mammalian γ-glutamyl transpeptidase. FASEB J 1994;8:661-4.
17. Letarte M, Vera S, Tran R, et al. Common acute lymphocytic leukemia antigen is identical to neutral endopeptidase. J Exp Med 1988;168:1247-53.
18. Erdos EG, Skidgel RA. Neutral endopeptidase 24.11 (en-kephalinase) and related regulators of peptide hormones. FASEB J 1989;3:145-51.
19. LeBien TW, McCormack RT. The common acute lymphoblastic leukemia antigen (CD10) - emancipation from a functional enigma. Blood 1989;73:625-35.
20. Malfroy B, Swerts JP, Guyon A, Roques BP, Schwartz JC. High-affinity enkephalin-degrading peptidase in brain is increased after morphine. Nature 1978;276:523-6.
21. Parish DC. The role of proteolysis in tumor invasion and growth. Endocrin Rel Cancer 1994;1:19-36.
22. Schrey M, Patel K. Role of regulatory peptides in the control of breast cancer cell growth and function. Endocr Rel Cancer 1994;1:42-70.
23. Berridge MJ. Inositol triphosphate and diacylglycerol as second messenger. Biochem J 1984;220:345-60.
24. IUPAC-IUB Commission on Biochemical Nomenclature. The nomenclature of lipids. Eur J Biochem 1977;79:11-21.
25. Centers for Disease Control. Revision of the CDC surveillance case definition for AIDS. MMWR 1987;36:1-15.
26. Leoni LM, Losa GA. Effect of cocaine and morphine on neutral endopeptidase activity of human peripheral blood mononuclear cells cultured with lectins. Cell Biochem Funct 1993;11:211-9.
27. Graber R, Leoni L, Carrel S, Losa GA. Lectins and anti-T monoclonal antibodies-induced changes of second messengers generating enzymes in human peripheral blood mononuclear cells. Cell Mol Biol 1993;39:45-54.
28. Florentin D, Sassi A, Roques BP. A highly sensitive fluorometric assay for "enkephalinase," a neutral metalloen-dopeptidase that releases tyrosine-glycine-glycine from en-kephalins. Anal Biochem 1984;141:62-9.
29. Palmer FBSC. An enzymatically coupled assay for rat brain polyphosphoinositide phosphodiesterase in an optimized reaction mixture. Anal Biochem 1985;150:345-52.
30. Graber R, Losa GA. Subcellular localization and kinetic properties of phosphatidylinositol 4,5-biphosphate phospholipase C and inositol phosphate enzymes from human peripheral blood mononuclear cells. Enzyme 1989;41:17-26.
31. Chen PS, Toribara TY, Warner H. Microdetermination of phosphorus. Anal Chem 1956;28:1756-9.
32. Losa GA, Morell A, Barandun S. Correlations between enzymatic and immunologic properties of human peripheral blood mononuclear cells. I. Ectoenzymes of normal and immunodeficient peripheral blood mononuclear cells. Am J Pathol 1982;107:191-201.
33. Ledeen RW, Yu RK. Gangliosides: structure, isolation, and analysis. Methods Enzymol 1982;83:139-51.
34. Ladisch S, Gillard B. A solvent partition method for micro-scale ganglioside purification. Anal Biochem 1985;146:220-31.
35. Hammond KS, Papermaster DS. Fluorometric assay of sialic acid in the picomole range: a modification of the thiobarbituric acid assay. Anal Biochem 1976;74:292-7.
36. Morell A, Losa GA, Barandun S. Determination of ectoenzymes activities in leukemic cells and established haematopoietic cell line. Am J Hematol 1986;21:289-96.
37. McDonough RJ, Madden JJ, Falek A, et al. Alterations of T and null lymphocyte frequencies in the peripheral blood of human opiate addicts: in vivo evidence for opiate receptor sites on T lymphocytes. J Immunol 1980;125:2539-43.
38. Heathcote J, Taylor KB. Immunity and nutrition in heroin drug addicts. Drug Alcohol Depend 1981;8:245-55.
39. Ruiz P, Cleary T, Nassiri M, Steele B. Human T lymphocyte subpopulation and NK cell alteration in persons exposed to cocaine. Clin Immunol Immunopathol 1994;70:245-50.
40. Layon J, Idris A, Warzynski M, et al. Altered T-lymphocyte subsets in hospitalized intravenous drug abusers. Arch Intern Med 1984;144:1376-80.
41. Donahoe M, Bueso-Ramos C, Donahoe F, Madden JJ, Falek A. Mechanistic implications of the findings that opiates and other drugs of abuse moderate T-cell surface receptors and antigenic markers. Ann NY Acad Sci 1987;496:711-8.
42. Peterson PK, Sharp BM, Gekker G, Jackson B, Balfour HHJ. Opiates, human peripheral blood mononuclear cells, and HIV. Adv Exp Med Biol 1991;288:171-8.
43. Fuchs D, Hausen A, Reibnegger G, Schonitzer D, Unter-weger B. Immune status of drug abusers. Cancer Detect Prev Suppl 1987;1:535-41.
44. Di Franco MJ, Marlink R, Hunter DJ, Tosteson T, Mayer K, Essex M. Association of immune activation with intravenous heroin use and methadone treatment in HIV-1 seropositive and seronegative subjects. J Acquir Immune Defic Syndr 1993;6:1297-300.
45. Peterson PK, Gekker G, Chao CC, Schul R, Molitor TW. Cocaine potentiates HIV-1 replication in human peripheral blood mononuclear cell cocultures. Involvement of transforming growth factor-beta. J Immunol 1991;146:81-4.
46. Peterson PK, Gekker G, Hu S, et al. Morphine amplifies HIV-1 expression in chronically infected promonocytes co-coltured with human brain cells. J Neuroimmunol 1994;50: 167-75.
47. Morell A, Losa GA, Barandun S. Surface marker, 5′-nucleotidase activity and in vitro functions of lymphocytes from patients with primary-humoral immunodeficiency. Clin Immunol Immunopathol 1985;35:9-15.
48. Matsuda K, Taki T, Hamanaka S, et al. Glycosphingolipid compositions of human T-lymphotropic virus type I (HTLV- I) and human immunodeficiency virus (HIV)-infected cell lines. Biochim Biophys Acta 1993;1168:123-9.
49. Lynn WS, Tweedle A, Wang CM. Human immunodeficiency virus (HIV-1) cytotoxicity: perturbation of the cell membrane and depression of phospholipid synthesis. Virology 1988;163:43-51.
50. Klein A, Mercure L, Gordon P, et al. The effect of HIV-1 infection on the lipid fatty acid content in the membrane of cultured lymphocytes. AIDS 1990;4:865-7.
51. Kaufmann R, Laroche D, Buchner K, et al. The HIV-1 surface protein gp120 has no effect on transmembrane signal transduction in T cells. J Acquir Immune Defic Syndr 1992; 5:760-70.
52. 1H NMR studies. FEBS Lett 1991;285:11-6.
53. + T cells in HIV-infected patients to markers of activation and progression: autoantibodies are closely associated with CD4 cell depletion. Immunology 1993;79:248-54.
54. Thompson LF, Seegmiller JE. Adenosine deaminase deficiency and severe combined immunodeficiency disease. Adv Enzymol 1980;51:67-78.
55. Salazar-Gonzales A. Reduced ecto-5′-nucleotidase activity and enhanced OKT10 and HLA-DR expression on CD8 (T suppressor/cytotoxic) lymphocytes in the acquired immune deficiency syndrome: evidence of CDS cell immaturity. J Immunol 1985;135:1778-83.